Figure 2: Results obtained with all the batches of the targeted vaccine that were approved to be released into the market using the guinea pig model of vaccine potency. The dots within each batch (1 to 11) represents a guinea pig and the lines and bars represents the mean NAb titers ± standard deviation, the dotted lines represent the split point for vaccine classification according to SENASA’s predetermined level of immunogenicity.